
IndraLab
Statements
Astemizole inhibits KCNH1. 42 / 52
6
1
|
35
7
reach
"A possible role of hEag1 in leukemia cell proliferation could be shown by growth and migration inhibition of the hEag1 expressing cell lines PLB-985, K562, UT-7 and HEL and primary clinical samples by the potassium channel blockers astemizole, imipramine, the hEag1 specific monoclonal antibody mAb56 and siRNA knockdown [XREF_BIBR]."
sparser
"To demonstrate the inhibition of the hEag1 by astemizole we used a −60 mV holding potential where activation kinetics of the current is fast ( xref ) and consequently block equilibrium develops fast, reaching steady-state within 3000 ms at various concentrations of the drug ( xref B)."
reach
"We interpret the increase in the Ca deposits as an indicator of an enhanced mineral matrix production of SaOS-2 cells when K channels are inhibited by 1 mM TEA.To analyze the contribution of hEag1 to the mineral matrix production of osteosarcoma cells, we used the hEag1 blocker astemizole."
sparser
"Open Channel Blockade of Eag1 Channels Reduces Tumor Progression in
Vivo —Because inhibition of Eag1 by the open channel blockers
astemizole and imipramine has been reported to inhibit proliferation of
several cell types in vitro ( xref , xref ), we tested if similar
effects could be observed in vivo ."
reach
"Tumor growth induced by implantation of Eag1 expressing cells was clearly inhibited in the group treated with astemizole (XREF_FIG), similar to growth inhibition observed after treatment with the well established cytotoxic drug cyclophosphamide (CPM) (applied at the maximal tolerable dose of 5 mg/kg)."